Prognosis
Covid Vaccine Front-Runners Will Soon See Their Moment of Truth
- Early data anticipated as soon as mid-September, analysts say
- Three companies may have data before key October FDA meeting
This article is for subscribers only.
Drugmakers made big promises for a quick turnaround on coronavirus vaccines. The moment of truth for the front-runners is coming as soon as this month.
The first results showing whether a vaccine can stop people from getting the virus could come by mid-September from AstraZeneca Plc, according to Airfinity Ltd., an analytics company that tracks drug trials. The drugmaker has pledged as many as 30 million doses to the U.K. by the end of the month.